Whither Magnetic Hyperthermia? A Tentative Roadmap

Author:

Rubia-Rodríguez Irene,Santana-Otero AntonioORCID,Spassov Simo,Tombácz EtelkaORCID,Johansson ChristerORCID,De La Presa PatriciaORCID,Teran Francisco J.ORCID,Morales María del Puerto,Veintemillas-Verdaguer SabinoORCID,Thanh Nguyen T. K.ORCID,Besenhard Maximilian O.ORCID,Wilhelm Claire,Gazeau Florence,Harmer Quentin,Mayes Eric,Manshian Bella B.ORCID,Soenen Stefaan J.ORCID,Gu Yuanyu,Millán ÁngelORCID,Efthimiadou Eleni K.,Gaudet Jeff,Goodwill PatrickORCID,Mansfield James,Steinhoff UweORCID,Wells James,Wiekhorst FrankORCID,Ortega DanielORCID

Abstract

The scientific community has made great efforts in advancing magnetic hyperthermia for the last two decades after going through a sizeable research lapse from its establishment. All the progress made in various topics ranging from nanoparticle synthesis to biocompatibilization and in vivo testing have been seeking to push the forefront towards some new clinical trials. As many, they did not go at the expected pace. Today, fruitful international cooperation and the wisdom gain after a careful analysis of the lessons learned from seminal clinical trials allow us to have a future with better guarantees for a more definitive takeoff of this genuine nanotherapy against cancer. Deliberately giving prominence to a number of critical aspects, this opinion review offers a blend of state-of-the-art hints and glimpses into the future of the therapy, considering the expected evolution of science and technology behind magnetic hyperthermia.

Publisher

MDPI AG

Subject

General Materials Science

Reference221 articles.

1. Has Received FDA Approval to Proceed with Its Streamlined Trial Protocol for the Next Stage of Pivotal U.S https://www.magforce.com/en/news/?article=325.

2. “Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy”. This NoCanTher Project Has Received Funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 685795 https://cordis.europa.eu/project/id/685795

3. Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy (RADIOMAG) www.cost-radiomag.eu/

4. Nanomedicine toward 2040

5. European Nanomedicine Characterization Lab http://www.euncl.eu/

Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3